AstraZeneca PLC (AZN)
76.98
-0.06
(-0.08%)
USD |
NASDAQ |
May 15, 16:00
77.04
+0.06
(+0.08%)
After-Hours: 20:00
AstraZeneca Price: 76.98 for May 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 14, 2024 | 77.87 | 77.93 | 77.02 | 77.04 | 3.526M |
| May 13, 2024 | 77.23 | 77.49 | 77.15 | 77.43 | 2.566M |
| May 10, 2024 | 77.77 | 77.94 | 77.14 | 77.18 | 3.607M |
| May 09, 2024 | 76.92 | 77.64 | 76.86 | 77.61 | 2.972M |
| May 08, 2024 | 76.77 | 77.16 | 76.61 | 76.97 | 5.060M |
| May 07, 2024 | 76.43 | 76.47 | 75.92 | 76.32 | 6.663M |
| May 06, 2024 | 75.84 | 75.93 | 75.54 | 75.76 | 6.457M |
| May 03, 2024 | 76.47 | 76.49 | 75.43 | 76.35 | 9.026M |
| May 02, 2024 | 76.26 | 76.41 | 75.75 | 75.80 | 10.04M |
| May 01, 2024 | 76.34 | 76.80 | 75.96 | 76.41 | 4.912M |
| Apr 30, 2024 | 75.72 | 76.14 | 75.32 | 75.88 | 8.547M |
| Apr 29, 2024 | 76.18 | 76.58 | 75.36 | 75.48 | 7.538M |
| Apr 26, 2024 | 75.00 | 75.49 | 74.59 | 75.17 | 6.688M |
| Apr 25, 2024 | 74.99 | 75.81 | 74.50 | 75.03 | 15.61M |
| Apr 24, 2024 | 71.41 | 71.47 | 70.68 | 71.20 | 6.138M |
| Apr 23, 2024 | 70.43 | 71.10 | 70.16 | 70.85 | 5.806M |
| Apr 22, 2024 | 69.67 | 70.49 | 69.38 | 70.13 | 5.184M |
| Apr 19, 2024 | 68.14 | 68.71 | 68.13 | 68.55 | 4.736M |
| Apr 18, 2024 | 68.25 | 68.78 | 68.16 | 68.36 | 4.006M |
| Apr 17, 2024 | 68.72 | 68.80 | 68.20 | 68.53 | 3.710M |
| Apr 16, 2024 | 68.29 | 68.60 | 68.02 | 68.26 | 5.362M |
| Apr 15, 2024 | 69.07 | 69.56 | 68.54 | 68.73 | 9.214M |
| Apr 12, 2024 | 69.66 | 69.82 | 68.60 | 68.93 | 9.121M |
| Apr 11, 2024 | 69.88 | 70.07 | 68.87 | 69.45 | 5.986M |
| Apr 10, 2024 | 67.59 | 68.16 | 67.42 | 68.11 | 7.716M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.38
Minimum
May 31 2019
77.61
Maximum
May 09 2024
58.36
Average
58.14
Median
Sep 15 2022
Price Benchmarks
| GSK PLC | 45.70 |
| Amgen Inc | 319.09 |
| Sanofi SA | 49.02 |
| Viking Therapeutics Inc | 78.02 |
| Fusion Pharmaceuticals Inc | 21.52 |
Price Related Metrics
| PE Ratio | 37.83 |
| PS Ratio | 5.051 |
| PEG Ratio | 1.088 |
| Price to Book Value | 6.374 |
| Price to Free Cash Flow | 41.57 |
| Earnings Yield | 2.64% |
| Market Cap | 238.67B |
| PEGY Ratio | 1.032 |
| Operating PE Ratio | 25.24 |
| Normalized PE Ratio | 34.62 |